2,935 $ | -0,085 $ | -2,81% |
1 Woche | 1 Monat | 3 Monate | Lfd. Jahr | 1 Jahr | 3 Jahre | |
Kurs | 2,94 $ | 3,07 $ | 1,46 $ | 1,34 $ | 3,23 $ | 2,05 $ |
Änderung | -0,17% | -4,40% | +101,03% | +119,03% | -9,13% | +43,17% |
Zeit | Titel | Quelle |
01.05.24 | Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 | PR Newswire |
09.04.24 | Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference | PR Newswire |
04.04.24 | Trevi Therapeutics to Participate in Upcoming April Events | PR Newswire |
02.04.24 | Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team | PR Newswire |
20.03.24 | Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates | PR Newswire |
13.03.24 | Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024 | PR Newswire |
Kaufen | Halten | Verkaufen | |
---|---|---|---|
Analysten | 0 | 0 | 0 |
Markt-Lotsen | 0 | 0 | 0 |